Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Advances in Colloid and Interface Science
|
November 26, 2024
Antifouling hydrogel with different mechanisms:Antifouling mechanisms, materials, preparations and applications
Guangling He, Wenyan Liu, Yuhua Liu, et al.
Genomics
|
June 9, 2026
Identification of single nucleotide polymorphisms of AADACL3 gene and their genetic associations with body weight and size traits in Chinese Holstein cows
Tong Yu, Yanhua Li, Shuqing Wei, et al.
Gels (Basel, Switzerland)
|
May 27, 2026
Poly(Vinyl Alcohol)-Saccharide Hydrogels with Size-Tunable Plasticization-to-Reinforcement for Flexible Sensors
Guangyan Wang, Zhenzhen Wang, Shuqing Wei, et al.
Frontiers in Cell and Developmental Biology
|
February 5, 2026
A multi-omics features-based approach integrating immunogenicity and inflammation enhances immunotherapy benefit in clear cell renal cell carcinoma
Yanfeng Xue, Feng Han, Shuqing Wei, et al.
Frontiers in Oncology
|
November 5, 2021
<i>CDCA7</i> Facilitates Tumor Progression by Directly Regulating <i>CCNA2</i> Expression in Esophageal Squamous Cell Carcinoma
Hongyi Li, Yongjia Weng, Shaojie Wang, et al.
International Immunopharmacology
|
January 18, 2025
Efficacy of immune checkpoint inhibitors in the treatment of soft tissue sarcoma: A systematic review and meta-analysis of clinical trials
Yang Cao, Wei Wang, Hairong Xu, et al.
BMC Medicine
|
January 16, 2026
Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study
Xiaoyu Li, Ruihong Dai, Qi Xu, et al.
Gynecologic Oncology
|
October 24, 2024
Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer
Guiling Li, Xiaofan Li, Rutie Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
Lingfang Xia, Keqiang Zhang, Ying Tang, et al.
Cancer Cell
|
December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
Zhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Advances in Colloid and Interface Science
|
November 26, 2024
Antifouling hydrogel with different mechanisms:Antifouling mechanisms, materials, preparations and applications
Guangling He, Wenyan Liu, Yuhua Liu, et al.
Genomics
|
June 9, 2026
Identification of single nucleotide polymorphisms of AADACL3 gene and their genetic associations with body weight and size traits in Chinese Holstein cows
Tong Yu, Yanhua Li, Shuqing Wei, et al.
Gels (Basel, Switzerland)
|
May 27, 2026
Poly(Vinyl Alcohol)-Saccharide Hydrogels with Size-Tunable Plasticization-to-Reinforcement for Flexible Sensors
Guangyan Wang, Zhenzhen Wang, Shuqing Wei, et al.
Frontiers in Cell and Developmental Biology
|
February 5, 2026
A multi-omics features-based approach integrating immunogenicity and inflammation enhances immunotherapy benefit in clear cell renal cell carcinoma
Yanfeng Xue, Feng Han, Shuqing Wei, et al.
Frontiers in Oncology
|
November 5, 2021
<i>CDCA7</i> Facilitates Tumor Progression by Directly Regulating <i>CCNA2</i> Expression in Esophageal Squamous Cell Carcinoma
Hongyi Li, Yongjia Weng, Shaojie Wang, et al.
International Immunopharmacology
|
January 18, 2025
Efficacy of immune checkpoint inhibitors in the treatment of soft tissue sarcoma: A systematic review and meta-analysis of clinical trials
Yang Cao, Wei Wang, Hairong Xu, et al.
BMC Medicine
|
January 16, 2026
Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study
Xiaoyu Li, Ruihong Dai, Qi Xu, et al.
Gynecologic Oncology
|
October 24, 2024
Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer
Guiling Li, Xiaofan Li, Rutie Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2025
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study
Lingfang Xia, Keqiang Zhang, Ying Tang, et al.
Cancer Cell
|
December 30, 2022
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
Zhihua Liu, Yahui Zhao, Pengzhou Kong, et al.
Page
of 3